Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jonas Abrahamsson

Professor, adjungerad

Jonas Abrahamsson
Professor, adjungerad
jonas.abrahamsson@pediat.gu.se

Postal Address: Drottning silvias barn o ungdomsjukh, 41685 Göteborg
Visiting Address: Drottning silvias barn o ungdomsjukh , 41685 Göteborg


Department of Pediatrics at Institute of Clinical Sciences (More Information)
Drottning Silvias Barn O ungdomsjukh
416 85 Göteborg
Visiting Address: Drottning Silvias Barn O ungdomsjukh , 416 85 Göteborg

Latest publications

Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
B. K. Albertsen, K. Grell, Jonas Abrahamsson, B. Lund, K. Vettenranta et al.
Journal of Clinical Oncology, Journal article 2019
Journal article

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
S Modvig, H O Madsen, S M Siitonen, S Rosthøj, A Tierens et al.
Leukemia, Journal article 2019
Journal article

Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.
Mari Wilhelmsson, Heidi Glosli, Marianne Ifversen, Jonas Abrahamsson, Jacek Winiarski et al.
Bone marrow transplantation, Journal article 2019
Journal article

Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.
Jacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, Maria Paerregaard, Jonas Abrahamsson et al.
Cancer chemotherapy and pharmacology, Journal article 2019
Journal article

Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
Sofie G Højfeldt, Benjamin O Wolthers, Morten Tulstrup, Jonas Abrahamsson, Ramneek Gupta et al.
British journal of haematology, Journal article 2019
Journal article

Showing 1 - 10 of 192

2019

Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
B. K. Albertsen, K. Grell, Jonas Abrahamsson, B. Lund, K. Vettenranta et al.
Journal of Clinical Oncology, Journal article 2019
Journal article

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
S Modvig, H O Madsen, S M Siitonen, S Rosthøj, A Tierens et al.
Leukemia, Journal article 2019
Journal article

Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.
Mari Wilhelmsson, Heidi Glosli, Marianne Ifversen, Jonas Abrahamsson, Jacek Winiarski et al.
Bone marrow transplantation, Journal article 2019
Journal article

Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.
Jacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, Maria Paerregaard, Jonas Abrahamsson et al.
Cancer chemotherapy and pharmacology, Journal article 2019
Journal article

Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
Sofie G Højfeldt, Benjamin O Wolthers, Morten Tulstrup, Jonas Abrahamsson, Ramneek Gupta et al.
British journal of haematology, Journal article 2019
Journal article

2018

Showing 1 - 10 of 192

Page Manager: Katarina Olinder Eriksson|Last update: 10/1/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?